David Fenard

Valbonne, 06560, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Enhanced anti-tumor activity by zinc finger repressor-driven epigenetic silencing of immune checkpoints and TGFBR2 in CAR-T cells and TILs.

Enhanced anti-tumor activity by zinc finger repressor-driven epigenetic silencing of immune checkpoints and TGFBR2 in CAR-T cells and TILs.

Journal: Molecular therapy. Oncology
Published: November 04, 2024

MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis.

MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis.

Journal: Journal of neuroinflammation
Published: April 26, 2024

IL23R-Specific CAR Tregs for the Treatment of Crohn's Disease.

IL23R-Specific CAR Tregs for the Treatment of Crohn's Disease.

Journal: Journal of Crohn's & colitis
Published: April 09, 2024

Epigenetic control of multiple genes with a lentiviral vector encoding transcriptional repressors fused to compact zinc finger arrays.

Epigenetic control of multiple genes with a lentiviral vector encoding transcriptional repressors fused to compact zinc finger arrays.

Journal: Molecular therapy. Methods & clinical development
Published: January 21, 2024

Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium.

Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium.

Journal: Molecular therapy. Methods & clinical development
Published: March 10, 2023

Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation.

Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation.

Journal: Gene therapy
Published: May 07, 2021

Temporary Reduction of Membrane CD4 with the Antioxidant MnTBAP Is Sufficient to Prevent Immune Responses Induced by Gene Transfer.

Temporary Reduction of Membrane CD4 with the Antioxidant MnTBAP Is Sufficient to Prevent Immune Responses Induced by Gene Transfer.

Journal: Molecular therapy. Methods & clinical development
Published: June 20, 2019

Constraints on Human CD34+ Cell Fate due to Lentiviral Vectors Can Be Relieved by Valproic Acid.

Constraints on Human CD34+ Cell Fate due to Lentiviral Vectors Can Be Relieved by Valproic Acid.

Journal: Human gene therapy
Published: April 13, 2019

Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency.

Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency.

Journal: Blood advances
Published: October 23, 2018

Peptides derived from evolutionarily conserved domains in Beclin-1 and Beclin-2 enhance the entry of lentiviral vectors into human cells.

Peptides derived from evolutionarily conserved domains in Beclin-1 and Beclin-2 enhance the entry of lentiviral vectors into human cells.

Journal: The Journal of biological chemistry
Published: June 08, 2017

Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent α-helical nanofibrils, concentrating viral particles.

Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent α-helical nanofibrils, concentrating viral particles.

Journal: Acta biomaterialia
Published: May 23, 2017

Improvement of De Novo Cholesterol Biosynthesis Efficiently Promotes the Production of Human Immunodeficiency Virus Type 1-Derived Lentiviral Vectors.

Improvement of De Novo Cholesterol Biosynthesis Efficiently Promotes the Production of Human Immunodeficiency Virus Type 1-Derived Lentiviral Vectors.

Journal: Human gene therapy methods
Published: January 03, 2017
Showing 1-12 of 22

Last Updated: 09/26/2026